Our study's findings contribute to the existing literature by suggesting that inflammatory markers (TNF-α and IL-1ß) and endothelial cell markers (E-selectin, ICAM-1, and VCAM-1) have neither cross-sectional nor longitudinal associations with cognitive decline in AD patients. This evidence concerns the gene VCAM1 and Alzheimer disease.